{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "New York",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "97364",
      "recalling_firm": "PFIZER INC",
      "address_1": "68 Hudson Blvd E",
      "address_2": "N/A",
      "postal_code": "10001-2188",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S. Nationwide",
      "recall_number": "D-0590-2025",
      "product_description": "Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05.  Case: NDC 0409-4933-10.",
      "product_quantity": "49,620 vials",
      "reason_for_recall": "Lack of Assurance of Sterility.",
      "recall_initiation_date": "20250804",
      "center_classification_date": "20250818",
      "report_date": "20250827",
      "code_info": "Lot #: LY3681, LY4360, LY4416, Exp. 02/28/2026"
    }
  ]
}